Login
glp-1 bulimia GLP-1 obesity drugs and eating disorders are not well understood yet : NPR
glp-1 bulimia GLP-1 obesity drugs and eating disorders are not well understood yet : NPR
glp-1 bulimia GLP-1 obesity drugs and eating disorders are not well understood yet : NPR
 Next

glp-1 bulimia GLP-1 obesity drugs and eating disorders are not well understood yet : NPR

Marsoni M251S
Sale price$24.01
Pay 4 payments of $6.00 a month.Shop Pay
Get it in 3 business days with 1 day shipping. Friday, May 29
FDA just approved Foundayo (orforglipron) Lilly's once daily oral GLP 1 for obesity. The headline: 12.4% average body weight reduction at the highest dose over 72 weeks in ATTAIN 1. That's 27 lbs How Does Orforglipron Affect Appetite Signaling Mechanisms? Prime Lab Peptides GLP 1s AgelessRx Microdosing GLP 1 Reviews: Real User Results & Experiences
Easy Shipping

Quick Dispatch:

Your glp-1 bulimia GLP-1 obesity drugs and eating disorders are not well understood yet : NPR orders ship within 1-2 business days.

Delivery Options:

  • Standard: 3-7 business days
  • Fast: 2-3 business days
  • Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your glp-1 bulimia GLP-1 obesity drugs and eating disorders are not well understood yet : NPR ships.

Need Help?
Questions about glp-1 bulimia GLP-1 obesity drugs and eating disorders are not well understood yet : NPR, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 bulimia GLP-1 obesity drugs and eating disorders are not well understood yet : NPR in your area.

Get Shipping Estimates

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy
4.6 ★★★★★
Based on 973 reviews
Sort
Highest Rating
Newest First
Oldest First
Product Reviews
S
Verified Purchase
Sparklez
Belleville, US
★★★★★ 4
Needs improvement
This trimmer really looks nice and it comes with some great attachments but what I found is that if you're going to switch from the line attachment to the little plastic attachment you have to sit somewhere where you can lay the item down because you have to unscrew one to put on the other. There is no way to easily switch from line trimming to attachment trimming without using the device that unhooks the screw. In my opinion that is really a detriment to the beauty of the overall working of this item the weight of it is good, it cuts good it automatically feeds the line out the color is nice and the price is great but then you have the issue of changing the line back and forth if this was improved I think I would definitely give it five stars I'm sorry but improvements need to be made.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on August 14, 2025
P
Verified Purchase
PJ re girl
Dallas, US
★★★★★ 5
This can do some cutting
So glad I purchased this for cutting thin annoying vines and really tall weeds. The resin blades have held up to cutting 1/2" stemmed vines, weeds, and tall johnson grass out on the farm. Have not had to change out the first set and it comes with 3 sets of blades, plus an allen wrench for changing out the rotating head to a wire weedeater. Very happy overall. Too, it is not heavy at all, and noticed the battery lasts longer compared to using the B&D 20v line weedeater .
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 11, 2025
K
Verified Purchase
Kenney Jackson
Charlottesville, US
★★★★★ 5
Very nice for the price
They’ve thought of everything for this. Easily switch heads. Easily change from trimming to edging. The line auto advances keeping you going when many others make you stop and make adjustments.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 8, 2025
P
Verified Purchase
PMShaw
Carnegie, US
★★★★★ 2
Faulty Trigger
This was the 3rd of 4 B & D Weed Trimmer's I have purchased in the past 4 months. My first B & D Weed Trimmer was purchased 3 years ago. The Trigger finally gave out. Every B & D Weed Trimmer has had a faulty trigger. They give out just past the 30 day return window - trying to get B & D to cover it on their warranty website is ridiculous! No one at Amazon knows anything either. So you either buy another or go to Ryobi...because you cant find any decent replacement blades for it either.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on August 29, 2025
H
Verified Purchase
huggable
Louisville, US
★★★★★ 5
Trimmer
Works great
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 26, 2025

recommand products

✨️ Liraglutide for Children 6 to <12 Years of Age with Obesity — A Randomized Trial ✨️ • This phase 3a trial randomly assigned obese children (6 to <12 years old) to
✨️ Liraglutide for Children 6 to <12 Years of Age with Obesity — A Randomized Trial ✨️ • This phase 3a trial randomly assigned obese children (6 to <12 years old) to
21.80
 Semaglutide
Semaglutide
23.43
 GLP-1 Receptor Agonists for Weight Control: Emerging Insights from Clinical Trials and Future Perspectives
GLP-1 Receptor Agonists for Weight Control: Emerging Insights from Clinical Trials and Future Perspectives
26.92
 Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial
Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial
26.48
 Full article: Semaglutide 2.4 mg long-term clinical outcomes in patients with obesity or overweight: a real-world retrospective cohort study in the United States (SCOPE 12 months)
Full article: Semaglutide 2.4 mg long-term clinical outcomes in patients with obesity or overweight: a real-world retrospective cohort study in the United States (SCOPE 12 months)
21.50